Vascular permeability, blood pressure, and organ damage in primary hypertension

Hypertension Research

Volumn 31, Issue 5, 2008, Pages 873-879

  Viazzi, Francesca ^a   Leoncini, Giovanna ^a   Ratto, Elena ^a   Parodi, Angelica ^a   Falqui, Valeria ^a   Conti, Novella ^a   Tomolillo, Cinzia ^a   Ravera, Giambattista ^b   Deferrari, Giacomo ^a   Pontremoli, Roberto ^a  

^a UNIVERSITY OF GENOA   (Italy)

^b UNIVERSITY OF GENOA   (Italy)

Author keywords

Hypertension; Left ventricular hypertrophy; Microalbuminuria; Transcapillary escape rate of albumin; Vascular permeability

Indexed keywords

ALBUMIN; CREATININE;

ADULT; ALBUMIN BLOOD LEVEL; ALBUMINURIA; ARTICLE; ATHEROSCLEROSIS; BLOOD PRESSURE MEASUREMENT; BLOOD PRESSURE MONITORING; BLOOD VESSEL PERMEABILITY; CARDIOVASCULAR RISK; CLINICAL ARTICLE; CONTROLLED STUDY; CREATININE BLOOD LEVEL; FEMALE; HEART INJURY; HEART LEFT VENTRICLE MASS; HUMAN; HYPERTENSION; KIDNEY INJURY; LOGISTIC REGRESSION ANALYSIS; MALE; ORGAN INJURY; PATHOPHYSIOLOGY; RISK ASSESSMENT; SYSTOLIC BLOOD PRESSURE; TARGET ORGAN;

ADULT; ALBUMINURIA; BLOOD PRESSURE; CAPILLARY PERMEABILITY; FEMALE; HUMANS; HYPERTENSION; HYPERTROPHY, LEFT VENTRICULAR; MALE; MIDDLE AGED; REGRESSION ANALYSIS; RETROSPECTIVE STUDIES; RISK FACTORS; SEVERITY OF ILLNESS INDEX;

EID: 46049121143     PISSN: 09169636     EISSN: 13484214     Source Type: Journal    
DOI: 10.1291/hypres.31.873     Document Type: Article

References (32)

1. European Society of Hypertension-European Society of Cardiology Guidelines Committee: 2003 European Society of Hypertension-European Society of Cardiology guidelines for the management of arterial hypertension. J Hypertens 2003; 21: 1011-1053.
2. Casale PN, Devereux RB, Milner M, et al: Value of echocardiographic measurement of left ventricular mass in predicting cardiovascular morbid events in hypertensive men. Ann Intern Med 1986; 105: 173-178.
3. Ghali JK, Liao Y, Simmons B, Castaner A, Cao G, Cooper RS: The prognostic role of left ventricular hypertrophy in patients with or without coronary artery disease. Ann Intern Med 1992; 117: 831-836.
4. Gardin JM, McClelland R, Kitzman D, et al: M-mode echocardiographic predictors of six- to seven-year incidence of coronary heart disease, stroke, congestive heart failure, and mortality in an elderly cohort (the Cardiovascular Health Study). Am J Cardiol 2001; 87: 1051-1057.
5. Jensen JS, Feldt-Rasmussen B, Strandgaard S, Schroll M, Borch-Johnsen K: Arterial hypertension, microalbuminuria, and risk of ischemic heart disease. Hypertension 2000; 35: 898-903.
6. Wachtell K, Ibsen H, Olsen MH, et al: Albuminuria and cardiovascular risk in hypertensive patients with left ventricular hypertrophy: the LIFE study. Ann Intern Med 2003; 139: 901-906.
7. Hillege HL, Fidler V, Diercks GF, et al, Prevention of Renal and Vascular End Stage Disease (PREVEND) Study Group: Urinary albumin excretion predicts cardiovascular and noncardiovascular mortality in general population. Circulation 2002; 106: 1777-1782.
8. Olsen MH, Wachtell K, Ibsen H, et al, LIFE Study Investigators: Reductions in albuminuria and in electrocardiographic left ventricular hypertrophy independently improve prognosis in hypertension: the LIFE study. J Hypertens 2006; 24: 775-781.
9. Ibsen H, Olsen MH, Wachtell K, et al: Reduction in albuminuria translates to reduction in cardiovascular events in hypertensive patients: losartan intervention for endpoint reduction in hypertension study. Hypertension 2005; 45: 198-202.
10. Pedrinelli R, Penno G, Dell'Omo G, et al: Transvascular and urinary leakage of albumin in atherosclerotic and hypertensive men. Hypertension 1998; 32: 318-323.
11. Pontremoli R, Sofia A, Ravera M, et al: Prevalence and clinical correlates of microalbuminuria in essential hypertension: the MAGIC study. Hypertension 1997; 30: 1135-1143.
12. Friedewald WT, Levi RI, Fredrickson DJ: Estimation of the concentration of low density lipoprotein cholesterol in plasma without use of the ultracentrifuge. Clin Chem 1972; 18: 499-502.
13. Cockcroft DW, Gault MH: Prediction of creatinine clearance from serum creatinine. Nephron 1976; 16: 31-41.
14. Schiller NB, Shah PM, Crawford M, et al: Recommendations for quantitation of the left ventricle by two-dimensional echocardiography. American Society of Echocardiography Committee on Standards, Subcommittee on Quantitation of Two-Dimensional Echocardiograms. J Am Soc Echocardiogr 1989; 2: 358-367.
15. De Simone G, Devereux RB, Daniels SR, Koren MJ, Meyer RA, Laragh JH: Effect of growth on variability of left ventricular mass: assessment of allometric signals in adults and children and of their capacity to predict cardiovascular risk. J Am Coll Cardiol 1995; 25: 1056-1062.
16. Dupont WD, Plummer WD Jr: Power and sample size calculations. A review and computer program. Control Clin Trials 1990; 11: 116-128.
17. Rizzoni D, Muiesan ML, Montani G, Zulli R, Calebich S, Agabiti-Rosei E: Relationship between initial cardiovascular structural changes and daytime and nighttime blood pressure monitoring. Am J Hypertens 1992; 5: 180-186.
18. Redon J, Liao Y, Lozano JV, Miralles A, Pascual JM, Cooper RS: Ambulatory blood pressure and microalbuminuria in essential hypertension: role of circadian variability. J Hypertens 1994; 12: 947-953.
19. Fesler P, Ribstein J, du Cailar G, Mimran A: Determinants of cardiorenal damage progression in normotensive and never-treated hypertensive subjects. Kidney Int 2005; 67: 1974-1979.
20. Cuspidi C, Meani S, Fusi V, et al: Isolated ambulatory hypertension and changes in target organ damage in treated hypertensive patients. J Hum Hypertens 2005; 19: 471-477.
21. Benjamin EJ, Levy D: Why is left ventricular hypertrophy so predictive of morbidity and mortality? Am J Med Sci 1999; 317: 168-175.
22. Ganau A, Devereux RB, Pickering TG, et al: Relation of left ventricular hemodynamic load'and contractile performance to left ventricular mass in hypertension. Circulation 1990; 81: 25-36.
23. Viazzi F, Leoncini G, Ratto E, et al: Microalbuminuria, blood pressure load, and systemic vascular permeability in primary hypertension. Am J Hypertens 2006; 19: 1183-1189.
24. Cottone S, Mule G, Nardi E, et al: Microalbuminuria and early endothelial activation in essential hypertension. J Hum Hypertens 2007; 21: 167-172.
25. Sciacqua A, Scozzafava A, Pujia A, et al: Interaction between vascular dysfunction and cardiac mass increases the risk of cardiovascular outcomes in essential hypertension. Eur Heart J 2005; 26: 921-921.
26. Feldt-Rasmussen B: Increased transcapillary escape rate of albumin in type 1 (insulin-dependent) diabetic patients with microalbuminuria. Diabetologia 1986; 290: 282-286.
27. Knudsen ST, Bek T, Poulsen PL, Hove MN, Rehling M, Mogensen CE: Macular edema reflects generalized vascular hyperpermeability in type 2 diabetic patients with retinopathy. Diabetes Care 2002; 25: 2328-2334.
28. Pedrinelli R, Penno G, Dell'Omo G, et al: Microalbuminuria and transcapillary albumin leakage in essential hypertension. Hypertension 1999; 34: 491-495.
29. Rocha R, Stier CT Jr: Pathophysiological effects of aldosterone in cardiovascular tissues. Trends Endocrinol Metab 2001; 12: 308-314.
30. Baldoncini R, Desideri G, Bellini C, et al: High plasma renin activity is combined with elevated urinary albumin excretion in essential hypertensive patients. Kidney Int 1999; 56: 1499-1504.
31. Schillaci G, Pirro M, Pucci G, et al: Different impact of the metabolic syndrome on left ventricular structure and function in hypertensive men and women. Hypertension 2006; 47: 881-886.
32. Schillaci G, Vaudo G, Reboldi G, et al: High-density lipoprotein cholesterol and left ventricular hypertrophy in essential hypertension. J Hypertens 2001; 19: 2265-2270.